4-(4-Chlorophenyl)-3-methylbut-3-en-2-oxime
4-(4-Chlorophenyl)-3-methylbut-3-en-2-oxime Basic information
- Product Name:
- 4-(4-Chlorophenyl)-3-methylbut-3-en-2-oxime
- Synonyms:
-
- AP-18
- 4-(4-Chlorophenyl)-3-methyl-3-buten-2-oneoxime
- 4-(4-Chlorophenyl)-3-methylbut-3-en-2-oxime
- 4-(4-Chlorophenyl)-3-methylbut-3-en-2-one oxime
- 3-Buten-2-one, 4-(4-chlorophenyl)-3-methyl-, oxime
- ganglia,TRP Channel,nerves,pain,AP18,Transient receptor potential channels,AP-18,AP 18,inhibit,nociceptive,root,hyperalgesia,Inhibitor,transduction,dorsal
- CAS:
- 55224-94-7
- MF:
- C11H12ClNO
- MW:
- 209.67
- Product Categories:
-
- Aromatics, Pharmaceuticals, Intermediates & Fine Chemicals
- Mol File:
- 55224-94-7.mol
4-(4-Chlorophenyl)-3-methylbut-3-en-2-oxime Chemical Properties
- storage temp.
- 2-8°C
- solubility
- DMSO: >10mg/mL
- form
- solid
- color
- white to off-white
- Stability:
- Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 2 months.
4-(4-Chlorophenyl)-3-methylbut-3-en-2-oxime Usage And Synthesis
Description
AP-
Uses
AP-18 is a selective TRPA1 channel blocker. AP-18 blocks the transient receptor potential ankyrin 1 receptors and can reduce chronic pain associated with arthritis. AP-18 reduces cinnamaldehyde-induced nociception in vivo and blocks cold- and mustard oil-induced activation of mouse TRPA1 but not capsaicin-induced activation. AP-18 reverses CFA-induced mechanical hyperalgesia in mice
Uses
AP-18 is a channel blocker that inhibits TRPA1.
Biological Activity
Reversible TRPA1 channel blocker (IC 50 values are 3.1 and 4.5 μ M at human and mouse TRPA1 respectively). Blocks cinnameldehyde-induced but not capsaicin-induced nociception and reverses mechanical hyperalgesia in vivo . Also blocks TRPA1 pore dilation (IC 50 = 10.3 μM for the inhibition of Yo-Pro uptake).
Biochem/physiol Actions
AP-18 is a selective TRPA1 channel blocker. Transient receptor potential A1 (TRPA1) plays a central role for chemical sensing in the pain pathway. AP-18 is a novel TRPA1 channel blocker. It reduces cinnamaldehyde-induced nociception in vivo and blocks cold- and mustard oil-induced activation of mouse TRPA1 but not capsaicin-induced activation demonstrating selectivity vs. TRPV11. AP-18 reverses CFA-induced mechanical hyperalgesia in mice.
in vivo
ap-18 blocks the transient receptor potential ankyrin 1 receptors and can reduce chronic pain associated with arthritis. this product is also capable to induce cinnamaldehyde-induced nociception and to block cold- and mustard oil-induced activation of mouse trpa1 but not capsaicin-induced activation 2. in addition, ap18 treatment reversed cfa-induced mechanical hyperalgesia in mice 2. thus, trpa1 is essential for sensitization of nociception.
storage
+4°C
References
References”Citations:
4-(4-Chlorophenyl)-3-methylbut-3-en-2-oximeSupplier
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 021-33632979
- info@tsbiochem.com
- Tel
- 021-61415566 800-8193336
- orderCN@merckgroup.com
- Tel
- 888-539-0666
- info@emmx.com
4-(4-Chlorophenyl)-3-methylbut-3-en-2-oxime(55224-94-7)Related Product Information
- A 967079
- SKF 96365 HYDROCHLORIDE
- Dofetilide
- 5-(4-Chlorophenyl)-furan-2-carboxylic acid 3,5<br>-dimethoxyphenylamide
- (S)-(+)-Benzyl glycidyl ether
- Benzyl alcohol
- Poly(methyl methacrylate)
- 4'-Hydroxyacetophenone
- 2-(1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL)-N-(4-ISOPROPYLPHENYL)ACETAMIDE
- POLYGODIAL